What is Palvella Therapeutics's net income?

Palvella Therapeutics (PVLA) reported net income of -$15.77M in Q1 2026.

How has Palvella Therapeutics's net income changed year-over-year?

Palvella Therapeutics's net income decreased by 92.6% year-over-year, from -$8.19M to -$15.77M.

What is the long-term trend for Palvella Therapeutics's net income?

Over 4 years (2021 to 2025), Palvella Therapeutics's net income has grown at a -2.3% compound annual growth rate (CAGR), from -$45.74M to -$41.72M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Palvella Therapeutics PVLA Net Income

Net Income at other companies

Relay Therapeutics, Inc.RLAY

-$73.29M+4.9%

Viridian Therapeutics, Inc.VRDN

-$104.9M-20.7%

ANI PharmaceuticalsANIP

$29.49M+88.1%

PrecigenPGEN

-$7.93M+85.4%

Arcutis Biotherapeutics, Inc.ARQT

-$11.3M+54.9%

Kodiak Sciences IncKOD

-$58.16M-1.2%

Other financials

Income statement

See full

Revenue$53.0K-97.3%

Operating income-$14.9M-88.7%

Net income-$15.8M-92.6%

EPS (diluted)-$1.20-62.2%

Balance sheet

See full

Cash & equivalents$206.4M+173%

Total debt$584.0K—

Total equity$232.3M+318%

Total assets$263.8M+232%

Cash flow

See full

Operating cash flow-$10.9M-60.5%

CapEx--100%

Free cash flow-$2.7M+72.0%

Valuation

See full

Market cap$1.7B+468%

Enterprise value$1.5B—

P/S41.6×—

Profitability

See full

Operating margin-183.2%-13.5pp

Net margin71.7%+40.4pp

FCF margin-99.8%-34.2pp

Returns & leverage

See full

Return on equity-34.2%—

Debt / equity0×—

Current ratio28.9×+20.0×

Where this comes from

Reported directly by Palvella Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Palvella Therapeutics's net income?: Palvella Therapeutics (PVLA) reported net income of -$15.77M in Q1 2026.
How has Palvella Therapeutics's net income changed year-over-year?: Palvella Therapeutics's net income decreased by 92.6% year-over-year, from -$8.19M to -$15.77M.
What is the long-term trend for Palvella Therapeutics's net income?: Over 4 years (2021 to 2025), Palvella Therapeutics's net income has grown at a -2.3% compound annual growth rate (CAGR), from -$45.74M to -$41.72M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.